191 related articles for article (PubMed ID: 28567043)
1. Simultaneous Subcutaneous and Intranasal Administration of a CAF01-Adjuvanted
Wern JE; Sorensen MR; Olsen AW; Andersen P; Follmann F
Front Immunol; 2017; 8():569. PubMed ID: 28567043
[TBL] [Abstract][Full Text] [Related]
2. Th1/Th17 T cell Tissue-Resident Immunity Increases Protection, But Is Not Required in a Vaccine Strategy Against Genital Infection With
Nguyen NDNT; Guleed S; Olsen AW; Follmann F; Christensen JP; Dietrich J
Front Immunol; 2021; 12():790463. PubMed ID: 34925371
[TBL] [Abstract][Full Text] [Related]
3. Intramuscular Priming and Intranasal Boosting Induce Strong Genital Immunity Through Secretory IgA in Minipigs Infected with Chlamydia trachomatis.
Lorenzen E; Follmann F; Bøje S; Erneholm K; Olsen AW; Agerholm JS; Jungersen G; Andersen P
Front Immunol; 2015; 6():628. PubMed ID: 26734002
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous Intramuscular And Intranasal Administration Of Chitosan Nanoparticles-Adjuvanted
Li Y; Wang C; Sun Z; Xiao J; Yan X; Chen Y; Yu J; Wu Y
Int J Nanomedicine; 2019; 14():8179-8193. PubMed ID: 31632026
[TBL] [Abstract][Full Text] [Related]
5. Dual-Isotope SPECT/CT Imaging of the Tuberculosis Subunit Vaccine H56/CAF01: Induction of Strong Systemic and Mucosal IgA and T-Cell Responses in Mice Upon Subcutaneous Prime and Intrapulmonary Boost Immunization.
Thakur A; Rodríguez-Rodríguez C; Saatchi K; Rose F; Esposito T; Nosrati Z; Andersen P; Christensen D; Häfeli UO; Foged C
Front Immunol; 2018; 9():2825. PubMed ID: 30555488
[TBL] [Abstract][Full Text] [Related]
6. Intranasal immunization with outer membrane vesicle pertussis vaccine confers broad protection through mucosal IgA and Th17 responses.
Raeven RHM; Rockx-Brouwer D; Kanojia G; van der Maas L; Bindels THE; Ten Have R; van Riet E; Metz B; Kersten GFA
Sci Rep; 2020 Apr; 10(1):7396. PubMed ID: 32355188
[TBL] [Abstract][Full Text] [Related]
7. A strong adjuvant based on glycol-chitosan-coated lipid-polymer hybrid nanoparticles potentiates mucosal immune responses against the recombinant Chlamydia trachomatis fusion antigen CTH522.
Rose F; Wern JE; Gavins F; Andersen P; Follmann F; Foged C
J Control Release; 2018 Feb; 271():88-97. PubMed ID: 29217176
[TBL] [Abstract][Full Text] [Related]
8. Route of Vaccine Administration Influences the Impact of Fms-Like Tyrosine Kinase 3 Ligand (Flt3L) on Chlamydial-Specific Protective Immune Responses.
Pais R; Omosun Y; Igietseme JU; Fujihashi K; Eko FO
Front Immunol; 2019; 10():1577. PubMed ID: 31333682
[TBL] [Abstract][Full Text] [Related]
9. A multi-subunit Chlamydia vaccine inducing neutralizing antibodies and strong IFN-γ⁺ CMI responses protects against a genital infection in minipigs.
Bøje S; Olsen AW; Erneholm K; Agerholm JS; Jungersen G; Andersen P; Follmann F
Immunol Cell Biol; 2016 Feb; 94(2):185-95. PubMed ID: 26268662
[TBL] [Abstract][Full Text] [Related]
10. Sublingual immunization with a subunit influenza vaccine elicits comparable systemic immune response as intramuscular immunization, but also induces local IgA and TH17 responses.
Gallorini S; Taccone M; Bonci A; Nardelli F; Casini D; Bonificio A; Kommareddy S; Bertholet S; O'Hagan DT; Baudner BC
Vaccine; 2014 Apr; 32(20):2382-8. PubMed ID: 24434044
[TBL] [Abstract][Full Text] [Related]
11. Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes.
Wizel B; Persson J; Thörn K; Nagy E; Harandi AM
Vaccine; 2012 Jun; 30(29):4361-8. PubMed ID: 22682292
[TBL] [Abstract][Full Text] [Related]
12. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.
Murthy AK; Chambers JP; Meier PA; Zhong G; Arulanandam BP
Infect Immun; 2007 Feb; 75(2):666-76. PubMed ID: 17118987
[TBL] [Abstract][Full Text] [Related]
13. Lactobacillus plantarum producing a Chlamydia trachomatis antigen induces a specific IgA response after mucosal booster immunization.
Kuczkowska K; Myrbråten I; Øverland L; Eijsink VGH; Follmann F; Mathiesen G; Dietrich J
PLoS One; 2017; 12(5):e0176401. PubMed ID: 28467432
[TBL] [Abstract][Full Text] [Related]
14. Genital Infiltrations of CD4
Erneholm K; Lorenzen E; Bøje S; Olsen AW; Jungersen G; Jensen HE; Cassidy JP; Andersen P; Agerholm JS; Follmann F
Front Microbiol; 2019; 10():197. PubMed ID: 30800114
[TBL] [Abstract][Full Text] [Related]
15. Influence of mucosal and parenteral immunization with a replication-defective mutant of HSV-2 on immune responses and protection from genital challenge.
Morrison LA; Da Costa XJ; Knipe DM
Virology; 1998 Mar; 243(1):178-87. PubMed ID: 9527927
[TBL] [Abstract][Full Text] [Related]
16. Microencapsulated IL-12 Drives Genital Tract Immune Responses to Intranasal Gonococcal Outer Membrane Vesicle Vaccine and Induces Resistance to Vaginal Infection with Diverse Strains of Neisseria gonorrhoeae.
Liu Y; Hammer LA; Daamen J; Stork M; Egilmez NK; Russell MW
mSphere; 2023 Feb; 8(1):e0038822. PubMed ID: 36537786
[TBL] [Abstract][Full Text] [Related]
17. Sublingual Boosting with a Novel Mucoadhesive Thermogelling Hydrogel Following Parenteral CAF01 Priming as a Strategy Against Chlamydia trachomatis.
Garcia-Del Rio L; Diaz-Rodriguez P; Pedersen GK; Christensen D; Landin M
Adv Healthc Mater; 2022 Jun; 11(11):e2102508. PubMed ID: 35124896
[TBL] [Abstract][Full Text] [Related]
18. Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen.
Hadad R; Marks E; Kalbina I; Schön K; Unemo M; Lycke N; Strid Å; Andersson S
APMIS; 2016 Dec; 124(12):1078-1086. PubMed ID: 27859689
[TBL] [Abstract][Full Text] [Related]
19. Immunization with chlamydial plasmid protein pORF5 DNA vaccine induces protective immunity against genital chlamydial infection in mice.
Li Z; Wang S; Wu Y; Zhong G; Chen D
Sci China C Life Sci; 2008 Nov; 51(11):973-80. PubMed ID: 18989639
[TBL] [Abstract][Full Text] [Related]
20. Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection.
Brown TH; David J; Acosta-Ramirez E; Moore JM; Lee S; Zhong G; Hancock RE; Xing Z; Halperin SA; Wang J
Vaccine; 2012 Jan; 30(2):350-60. PubMed ID: 22075089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
